Skip to main content

Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Trial of X4P-001 in Patients With Advanced Renal Cell Carcinoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Trial of X4P-001 in Patients With Advanced Renal Cell Carcinoma

The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study

A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis

ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 149
  • Page 150
  • Page 151
  • Page 152
  • Page 153
  • Page 154
  • Page 155
  • Page 156
  • Page 157
  • …
  • Next page Next
  • Last page Last
Subscribe to